{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:41:59Z","timestamp":1791250919017,"version":"4.1.0"},"reference-count":265,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"crossref","award":["601\/14"],"award-info":[{"award-number":["601\/14"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"crossref","award":["806\/14"],"award-info":[{"award-number":["806\/14"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"crossref","award":["663\/16"],"award-info":[{"award-number":["663\/16"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ISF-UGB joint research program","award":["2277\/15"],"award-info":[{"award-number":["2277\/15"]}]},{"DOI":"10.13039\/100001698","name":"Israel Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001742","name":"United States-Israel Binational Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001742","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009578","name":"Mizutani Foundation for Glycoscience","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009578","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drupjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.drup.2016.10.001","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T02:43:12Z","timestamp":1476067392000},"page":"54-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":216,"special_numbering":"C","title":["Heparanase: From basic research to therapeutic applications in cancer and inflammation"],"prefix":"10.1016","volume":"29","author":[{"given":"Israel","family":"Vlodavsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilanit","family":"Boyango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach","family":"Gutter-Kapon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Elkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph D.","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neta","family":"Ilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2016.10.001_bib0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCRESAHA.108.192625","article-title":"Getting neointimal: the emergence of heparanase into the vascular matrix","volume":"104","author":"Aalkjaer","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0010","doi-asserted-by":"crossref","first-page":"13568","DOI":"10.1074\/jbc.M413370200","article-title":"Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase","volume":"280","author":"Abboud-Jarrous","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0015","doi-asserted-by":"crossref","first-page":"18167","DOI":"10.1074\/jbc.M801327200","article-title":"Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment","volume":"283","author":"Abboud-Jarrous","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1479-5876-9-219","article-title":"TLR4 dependent heparan sulphate-induced pancreatic inflammatory response is IRF3-mediated","volume":"9","author":"Akbarshahi","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.drup.2016.10.001_bib0025","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1083\/jcb.200106075","article-title":"Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition","volume":"155","author":"Allen","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0030","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.mayocp.2015.04.025","article-title":"Non-Hodgkin lymphoma: diagnosis and treatment","volume":"90","author":"Ansell","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.drup.2016.10.001_bib0035","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1096\/fj.10-156372","article-title":"Post-transcriptional regulation of heparanase gene expression by a 3\u2032 AU-rich element","volume":"24","author":"Arvatz","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.drup.2016.10.001_bib0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10555-011-9288-x","article-title":"The heparanase system and tumor metastasis: is heparanase the seed and soil?","volume":"30","author":"Arvatz","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.drup.2016.10.001_bib0045","doi-asserted-by":"crossref","first-page":"11150","DOI":"10.1038\/ncomms11150","article-title":"Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1","volume":"7","author":"Au Yeung","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2016.10.001_bib0050","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1182\/blood-2012-03-417139","article-title":"Inactivation of heparan sulfate 2-O-sulfotransferase accentuates neutrophil infiltration during acute inflammation in mice","volume":"120","author":"Axelsson","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.drup.2016.10.001_bib0055","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ncb2502","article-title":"Syndecan\u2013syntenin\u2013ALIX regulates the biogenesis of exosomes","volume":"14","author":"Baietti","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0060","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/CIRCRESAHA.108.180695","article-title":"Heparanase alters arterial structure, mechanics, and repair following endovascular stenting in mice","volume":"104","author":"Baker","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0065","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.jacc.2011.11.057","article-title":"Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance","volume":"59","author":"Baker","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.drup.2016.10.001_bib0070","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1111\/j.1742-4658.2010.07799.x","article-title":"Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis","volume":"277","author":"Barash","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.drup.2016.10.001_bib0075","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/leu.2014.121","article-title":"Heparanase enhances myeloma progression via CXCL10 downregulation","volume":"28","author":"Barash","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2016.10.001_bib0080","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/gutjnl-2011-301008","article-title":"Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesis","volume":"62","author":"Baumgart","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.drup.2016.10.001_bib0085","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/modpathol.3880435","article-title":"Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions","volume":"14","author":"Bayer-Garner","year":"2001","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.drup.2016.10.001_bib0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7827-2-3","article-title":"Syndecans in tumor cell adhesion and signaling","volume":"2","author":"Beauvais","year":"2004","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.drup.2016.10.001_bib0095","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1158\/0008-5472.CAN-16-0232","article-title":"Syndecan-1 (CD138) suppresses apoptosis in multiple myeloma by activating IGF1 receptor: prevention by synstatinIGF1R inhibits tumor growth","volume":"76","author":"Beauvais","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00384-004-0677-2","article-title":"Biochemical and immunohistochemical analysis of glycosaminoglycans in inflamed and non-inflamed intestinal mucosa of patients with Crohn\u2019s disease","volume":"20","author":"Belmiro","year":"2005","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.drup.2016.10.001_bib0105","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biocel.2007.09.003","article-title":"Low and high affinity receptors mediate cellular uptake of heparanase","volume":"40","author":"Ben-Zaken","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0110","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.176.11.6417","article-title":"Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells","volume":"176","author":"Benhamron","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.drup.2016.10.001_bib0115","doi-asserted-by":"crossref","first-page":"e35602","DOI":"10.1371\/journal.pone.0035602","article-title":"Dissociation between mature phenotype and impaired transmigration in dendritic cells from heparanase-deficient mice","volume":"7","author":"Benhamron","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2016.10.001_bib0120","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1146\/annurev.biochem.68.1.729","article-title":"Functions of cell surface heparan sulfate proteoglycans","volume":"68","author":"Bernfield","year":"1999","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.drup.2016.10.001_bib0125","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/ATVBAHA.112.254961","article-title":"Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression","volume":"33","author":"Blich","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol. (ATVB)"},{"key":"10.1016\/j.drup.2016.10.001_bib0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2015.03.002","article-title":"Shaping of the tumor microenvironment: stromal cells and vessels","volume":"34","author":"Blonska","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI32335","article-title":"Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function","volume":"118","author":"Bode","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drup.2016.10.001_bib0140","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.cellsig.2012.01.018","article-title":"The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis","volume":"24","author":"Bode","year":"2012","journal-title":"Cell Signal."},{"key":"10.1016\/j.drup.2016.10.001_bib0145","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1158\/0008-5472.CAN-13-2962","article-title":"Heparanase cooperates with Ras to drive breast and skin tumorigenesis","volume":"74","author":"Boyango","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1172\/JCI76566","article-title":"Heparan sulfate mimetic PG545-mediated antilymphoma effects require TLR9-dependent NK cell activation","volume":"126","author":"Brennan","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drup.2016.10.001_bib0155","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/modpathol.2009.115","article-title":"Heparanase expression by Barrett\u2019s epithelium and during esophageal carcinoma progression","volume":"22","author":"Brun","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.drup.2016.10.001_bib0160","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1096\/fj.04-3211fje","article-title":"Conditional signaling by Toll-like receptor 4","volume":"19","author":"Brunn","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.drup.2016.10.001_bib0165","doi-asserted-by":"crossref","first-page":"D233","DOI":"10.1093\/nar\/gkn663","article-title":"The Carbohydrate-Active EnZymes database (CAZy): an expert resource for glycogenomics","volume":"37","author":"Cantarel","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0170","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3748\/wjg.v11.i6.903","article-title":"Tumor metastasis and the reciprocal regulation of heparanase gene expression by nuclear factor kappa B in human gastric carcinoma tissue","volume":"11","author":"Cao","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.drup.2016.10.001_bib0175","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.bcp.2013.02.023","article-title":"Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models","volume":"85","author":"Cassinelli","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drup.2016.10.001_bib0180","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.10292","article-title":"Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases","author":"Cassinelli","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2016.10.001_bib0185","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/j.gastro.2012.07.009","article-title":"Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation","volume":"143","author":"Chiba","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drup.2016.10.001_bib0190","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/labinvest.3700050","article-title":"A porous defense: the leaky epithelial barrier in intestinal disease","volume":"84","author":"Clayburgh","year":"2004","journal-title":"Lab. Investig."},{"key":"10.1016\/j.drup.2016.10.001_bib0195","doi-asserted-by":"crossref","first-page":"10077","DOI":"10.1158\/0008-5472.CAN-08-2910","article-title":"Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression","volume":"68","author":"Cohen-Kaplan","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0200","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/ijc.23898","article-title":"Heparanase induces VEGF C and facilitates tumor lymphangiogenesis","volume":"123","author":"Cohen-Kaplan","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2016.10.001_bib0205","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1074\/jbc.M111.271346","article-title":"Heparanase induces Signal Transducer and Activator of Transcription (STAT) protein phosphorylation: preclinical and clinical significance in head and neck cancer","volume":"287","author":"Cohen-Kaplan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0210","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/01.ATV.0000085630.24353.3D","article-title":"Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface","volume":"23","author":"Constantinescu","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol. (ATVB)"},{"key":"10.1016\/j.drup.2016.10.001_bib0215","doi-asserted-by":"crossref","first-page":"e1047556","DOI":"10.1080\/23723556.2015.1047556","article-title":"Heparanase tailors syndecan for exosome production","volume":"3","author":"David","year":"2016","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.drup.2016.10.001_bib0220","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0969-2126(01)00220-9","article-title":"Structures and mechanisms of glycosyl hydrolases","volume":"3","author":"Davies","year":"1995","journal-title":"Structure"},{"key":"10.1016\/j.drup.2016.10.001_bib0225","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(98)09267-8","article-title":"Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease","volume":"354","author":"Day","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2016.10.001_bib0230","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1189\/jlb.0507315","article-title":"Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1","volume":"82","author":"de Mestre","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"July","key":"10.1016\/j.drup.2016.10.001_bib0235","article-title":"Microenvironment drug resistance in multiple myeloma: emerging new players","author":"Di Marzo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2016.10.001_bib0240","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/modpathol.3800603","article-title":"Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence","volume":"19","author":"Doviner","year":"2006","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.drup.2016.10.001_bib0245","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1593\/neo.06577","article-title":"Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival","volume":"8","author":"Doweck","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.drup.2016.10.001_bib0250","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s10637-009-9245-5","article-title":"The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy","volume":"28","author":"Dredge","year":"2010","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.drup.2016.10.001_bib0255","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/bjc.2011.11","article-title":"PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models","volume":"104","author":"Dredge","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2016.10.001_bib0260","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.semcdb.2014.08.006","article-title":"mTOR and autophagy: a dynamic relationship governed by nutrients and energy","volume":"36","author":"Dunlop","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0265","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/jnci\/djh230","article-title":"Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis","volume":"96","author":"Edovitsky","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drup.2016.10.001_bib0270","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1182\/blood-2005-08-3301","article-title":"Role of endothelial heparanase in delayed-type hypersensitivity","volume":"107","author":"Edovitsky","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.drup.2016.10.001_bib0275","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-4889(01)00132-X","article-title":"Internalization and stepwise degradation of heparan sulfate proteoglycans in rat hepatocytes","volume":"1541","author":"Egeberg","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drup.2016.10.001_bib0280","first-page":"1299","article-title":"The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma","volume":"7","author":"El-Assal","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0285","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1096\/fj.00-0895fje","article-title":"Heparanase as mediator of angiogenesis: mode of action","volume":"15","author":"Elkin","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.drup.2016.10.001_bib0290","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nchembio.2007.41","article-title":"Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate","volume":"3","author":"Escobar Galvis","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0295","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/0008-5472.CAN-13-0661","article-title":"Targeting the tumor microenvironment: from understanding pathways to effective clinical trials","volume":"73","author":"Fang","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0300","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","article-title":"The pancreas cancer microenvironment","volume":"18","author":"Feig","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0305","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1055\/s-2007-982088","article-title":"PI-88 and novel heparan sulfate mimetics inhibit angiogenesis","volume":"33","author":"Ferro","year":"2007","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.drup.2016.10.001_bib0310","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2010.080639","article-title":"Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice","volume":"176","author":"Floer","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.drup.2016.10.001_bib0315","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/boc.201500010","article-title":"Syntenin and syndecan in the biogenesis of exosomes","volume":"107","author":"Friand","year":"2015","journal-title":"Biol. Cell"},{"key":"10.1016\/j.drup.2016.10.001_bib0320","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1158\/0008-5472.CAN-08-1837","article-title":"Structure-function approach identifies a COOH-terminal domain that mediates heparanase signaling","volume":"69","author":"Fux","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0325","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.tibs.2009.06.005","article-title":"Heparanase: busy at the cell surface","volume":"34","author":"Fux","year":"2009","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.drup.2016.10.001_bib0330","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ajpath.2015.12.008","article-title":"Heparanase is essential for the development of acute experimental glomerulonephritis","volume":"186","author":"Garsen","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.drup.2016.10.001_bib0335","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2015091070","article-title":"Endothelin-1 induces proteinuria by heparanase-mediated disruption of the glomerular glycocalyx","author":"Garsen","year":"2016","journal-title":"J. Am. Soc. Nephrol. (JASN)"},{"key":"10.1016\/j.drup.2016.10.001_bib0340","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2337\/db11-1024","article-title":"Heparanase is essential for the development of diabetic nephropathy in mice","volume":"61","author":"Gil","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.drup.2016.10.001_bib0345","doi-asserted-by":"crossref","first-page":"23536","DOI":"10.1074\/jbc.M400554200","article-title":"Heparanase induces endothelial cell migration via protein kinase B\/Akt activation","volume":"279","author":"Gingis-Velitski","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0350","doi-asserted-by":"crossref","first-page":"44084","DOI":"10.1074\/jbc.M402131200","article-title":"Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans","volume":"279","author":"Gingis-Velitski","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0355","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.matbio.2013.02.008","article-title":"Versatile role of heparanase in inflammation","volume":"32","author":"Goldberg","year":"2013","journal-title":"Matrix Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0360","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.2337\/db14-0001","article-title":"Role of heparanase-driven inflammatory cascade in pathogenesis of diabetic nephropathy","volume":"63","author":"Goldberg","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.drup.2016.10.001_bib0365","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/excr.2002.5651","article-title":"Human heparanase is localized within lysosomes in a stable form","volume":"281","author":"Goldshmidt","year":"2002","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0370","doi-asserted-by":"crossref","first-page":"e109596","DOI":"10.1371\/journal.pone.0109596","article-title":"Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4","volume":"9","author":"Goodall","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2016.10.001_bib0375","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1096\/fj.02-0739rev","article-title":"Syndecans in inflammation","volume":"17","author":"Gotte","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.drup.2016.10.001_bib0380","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.gde.2009.11.004","article-title":"Inflammation and oncogenesis: a vicious connection","volume":"20","author":"Grivennikov","year":"2010","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.drup.2016.10.001_bib0385","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.drup.2016.10.001_bib0390","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1158\/0008-5472.CAN-15-1975","article-title":"Heparanase 2 attenuates head and neck tumor vascularity and growth","volume":"76","author":"Gross-Cohen","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0395","doi-asserted-by":"crossref","first-page":"22556","DOI":"10.18632\/oncotarget.8003","article-title":"Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage","volume":"7","author":"Gross-Cohen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2016.10.001_bib0400","first-page":"1415","article-title":"Comparison of the effects of differentially sulphated bovine kidney- and porcine intestine-derived heparan sulphate on breast carcinoma cellular behaviour","volume":"31","author":"Guo","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.drup.2016.10.001_bib0405","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1053\/j.gastro.2007.08.001","article-title":"Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study","volume":"133","author":"Gupta","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drup.2016.10.001_bib0410","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrm1681","article-title":"Heparan sulphate proteoglycans: the sweet side of development","volume":"6","author":"Hacker","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0415","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1038\/ncomms7985","article-title":"Heparanase is a host enzyme required for herpes simplex virus-1 release from cells","volume":"6","author":"Hadigal","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2016.10.001_bib0420","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ab.2009.09.007","article-title":"Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening","volume":"396","author":"Hammond","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.drup.2016.10.001_bib0425","doi-asserted-by":"crossref","first-page":"e52175","DOI":"10.1371\/journal.pone.0052175","article-title":"PG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma model","volume":"7","author":"Hammond","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2016.10.001_bib0430","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fonc.2014.00195","article-title":"The role of heparanase and sulfatases in the modification of heparan sulfate proteoglycans within the tumor microenvironment and opportunities for novel cancer therapeutics","volume":"4","author":"Hammond","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2016.10.001_bib0435","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.drup.2016.10.001_bib0440","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4161\/trns.19998","article-title":"The endoglycosidase heparanase enters the nucleus of T lymphocytes and modulates H3 methylation at actively transcribed genes via the interplay with key chromatin modifying enzymes","volume":"3","author":"He","year":"2012","journal-title":"Transcription"},{"key":"10.1016\/j.drup.2016.10.001_bib0445","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s00018-012-0930-8","article-title":"Heparanase enzyme in chronic inflammatory bowel disease and colon cancer","volume":"69","author":"Hermano","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.drup.2016.10.001_bib0450","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju332","article-title":"Macrophage polarization in pancreatic carcinoma: role of heparanase enzyme","volume":"106","author":"Hermano","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drup.2016.10.001_bib0455","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1006\/jaut.1995.0055","article-title":"Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity","volume":"8","author":"Hershkoviz","year":"1995","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.drup.2016.10.001_bib0460","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/blood-2009-01-199604","article-title":"Bortezomib induces canonical nuclear factor-kappa B activation in multiple myeloma cells","volume":"114","author":"Hideshima","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.drup.2016.10.001_bib0465","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.bjc.6605854","article-title":"Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation","volume":"103","author":"Hiraoka","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2016.10.001_bib0470","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1007\/s11605-008-0628-2","article-title":"High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA and via HIF1a to HB-EGF and bFGF","volume":"12","author":"Hoffmann","year":"2008","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.drup.2016.10.001_bib0475","doi-asserted-by":"crossref","first-page":"15659","DOI":"10.1021\/bi002080p","article-title":"Identification of active-site residues of the pro-metastatic endoglycosidase heparanase","volume":"39","author":"Hulett","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.drup.2016.10.001_bib0480","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1172\/JCI42754","article-title":"Inhibiting Cxcr2 disrupts tumor\u2013stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma","volume":"121","author":"Ijichi","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drup.2016.10.001_bib0485","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.biocel.2006.06.004","article-title":"Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis","volume":"38","author":"Ilan","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0490","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1080\/15548627.2015.1115174","article-title":"Function from within: autophagy induction by HPSE\/heparanase\u2014new possibilities for intervention","volume":"11","author":"Ilan","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2016.10.001_bib0495","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1582-4934.2010.01236.x","article-title":"Proteoglycans in cancer biology, tumour microenvironment and angiogenesis","volume":"15","author":"Iozzo","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.drup.2016.10.001_bib0500","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.4049\/jimmunol.168.10.5233","article-title":"Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4","volume":"168","author":"Johnson","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.drup.2016.10.001_bib0505","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1172\/JCI57158","article-title":"Therapeutic strategies for the clinical blockade of IL-6\/gp130 signaling","volume":"121","author":"Jones","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drup.2016.10.001_bib0510","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.18632\/oncotarget.3214","article-title":"The heparan sulfate mimetic PG545 interferes with Wnt\/beta-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine","volume":"6","author":"Jung","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2016.10.001_bib0515","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1038\/oncsis.2016.5","article-title":"Heparanase-induced shedding of syndecan-1\/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins","volume":"5","author":"Jung","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.drup.2016.10.001_bib0520","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nm0698-691","article-title":"Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2","volume":"4","author":"Kato","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2016.10.001_bib0525","first-page":"8749","article-title":"High heparanase activity in multiple myeloma is associated with elevated microvessel density","volume":"63","author":"Kelly","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0530","first-page":"4655","article-title":"Heparanase expression in primary and metastatic pancreatic cancer","volume":"61","author":"Koliopanos","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0535","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/oby.2008.607","article-title":"Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes","volume":"17","author":"Kopp","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.drup.2016.10.001_bib0540","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ncb2204","article-title":"Lysosomal positioning coordinates cellular nutrient responses","volume":"13","author":"Korolchuk","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0545","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1517\/13543784.17.11.1769","article-title":"PI-88: a novel inhibitor of angiogenesis","volume":"17","author":"Kudchadkar","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.drup.2016.10.001_bib0550","article-title":"Involvement of heparanase in empyema: implication for novel therapeutic approaches","volume":"6","author":"Lapidot","year":"2015","journal-title":"J. Clin. Cell. Immunol."},{"key":"10.1016\/j.drup.2016.10.001_bib0555","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1182\/blood-2015-05-646497","article-title":"Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells","volume":"127","author":"Larrue","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.drup.2016.10.001_bib0560","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1586\/17474086.2014.882764","article-title":"Current strategies for treatment of relapsed\/refractory multiple myeloma","volume":"7","author":"Laubach","year":"2014","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.drup.2016.10.001_bib0565","doi-asserted-by":"crossref","first-page":"42732","DOI":"10.1074\/jbc.M405382200","article-title":"Heparan sulfate structure in mice with genetically modified heparan sulfate production","volume":"279","author":"Ledin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0570","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/1078-0432.CCR-07-1866","article-title":"Function of heparanase in prostate tumorigenesis: potential for therapy","volume":"14","author":"Lerner","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0575","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1172\/JCI43792","article-title":"Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice","volume":"121","author":"Lerner","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drup.2016.10.001_bib0580","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s00018-013-1496-9","article-title":"Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice","volume":"71","author":"Lerner","year":"2014","journal-title":"Cell. Mol. Life Sci. (CMLS)"},{"key":"10.1016\/j.drup.2016.10.001_bib0585","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ccr.2011.03.009","article-title":"Stat3\/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer","volume":"19","author":"Lesina","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2016.10.001_bib0590","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pharmthera.2011.03.009","article-title":"Targeting autophagy during cancer therapy to improve clinical outcomes","volume":"131","author":"Levy","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drup.2016.10.001_bib0595","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(03)01478-5","article-title":"Heterodimer formation is essential for heparanase enzymatic activity","volume":"308","author":"Levy-Adam","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drup.2016.10.001_bib0600","doi-asserted-by":"crossref","first-page":"20457","DOI":"10.1074\/jbc.M414546200","article-title":"Identification and characterization of heparin\/heparan sulfate binding domains of the endoglycosidase heparanase","volume":"280","author":"Levy-Adam","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0605","doi-asserted-by":"crossref","first-page":"e2319","DOI":"10.1371\/journal.pone.0002319","article-title":"Heparanase facilitates cell adhesion and spreading by clustering of cell surface heparan sulfate proteoglycans","volume":"3","author":"Levy-Adam","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2016.10.001_bib0610","doi-asserted-by":"crossref","first-page":"28010","DOI":"10.1074\/jbc.M110.116384","article-title":"Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity","volume":"285","author":"Levy-Adam","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0615","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1160\/TH09-02-0091","article-title":"Heparin, heparan sulfate and heparanase in inflammatory reactions","volume":"102","author":"Li","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.drup.2016.10.001_bib0620","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1073\/pnas.0502287102","article-title":"In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drup.2016.10.001_bib0625","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/art.23489","article-title":"Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patients with rheumatoid arthritis","volume":"58","author":"Li","year":"2008","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.drup.2016.10.001_bib0630","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neulet.2011.12.038","article-title":"Heparanase overexpression reduces carrageenan-induced mechanical and cold hypersensitivity in mice","volume":"511","author":"Li","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drup.2016.10.001_bib0635","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3892\/ijmm.2013.1292","article-title":"Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase","volume":"31","author":"Li","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.drup.2016.10.001_bib0640","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI113953","article-title":"Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins","volume":"83","author":"Lider","year":"1989","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drup.2016.10.001_bib0645","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/eji.1830200306","article-title":"Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity","volume":"20","author":"Lider","year":"1990","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.drup.2016.10.001_bib0650","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1937-6448(09)76003-4","article-title":"Interactions between heparan sulfate and proteins-design and functional implications","volume":"276","author":"Lindahl","year":"2009","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0655","doi-asserted-by":"crossref","first-page":"11384","DOI":"10.3748\/wjg.v20.i32.11384","article-title":"Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence","volume":"20","author":"Liu","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.drup.2016.10.001_bib0660","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJM199305203282001","article-title":"Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group","volume":"328","author":"Lowenfels","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2016.10.001_bib0665","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1182\/blood-2006-08-043232","article-title":"Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma","volume":"109","author":"Mahtouk","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.drup.2016.10.001_bib0670","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.drup.2016.10.001_bib0675","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1182\/blood-2010-01-266072","article-title":"A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils","volume":"116","author":"Massena","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.drup.2016.10.001_bib0680","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1172\/JCI112104","article-title":"Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes","volume":"76","author":"Matzner","year":"1985","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drup.2016.10.001_bib0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0707182","article-title":"Heparanase: a target for drug discovery in cancer and inflammation","volume":"151","author":"McKenzie","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drup.2016.10.001_bib0690","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1006\/bbrc.2000.3586","article-title":"Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member","volume":"276","author":"McKenzie","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drup.2016.10.001_bib0695","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.exer.2008.09.002","article-title":"Lacritin and other new proteins of the lacrimal functional unit","volume":"88","author":"McKown","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0700","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1158\/1078-0432.CCR-07-2223","article-title":"The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance","volume":"14","author":"Meads","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0705","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.seminhematol.2015.01.007","article-title":"Novel targeted therapies in diffuse large B-cell lymphoma","volume":"52","author":"Mehta-Shah","year":"2015","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.drup.2016.10.001_bib0710","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1158\/0008-5472.CAN-10-3402","article-title":"Role of heparanase in radiation-enhanced invasiveness of pancreatic carcinoma","volume":"71","author":"Meirovitz","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0715","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/1078-0432.CCR-08-1270","article-title":"Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias","volume":"15","author":"Mitsiades","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0720","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1084\/jem.186.8.1357","article-title":"Neutrophil emigration in the skin, lungs, and peritoneum: different requirements for CD11\/CD18 revealed by CD18-deficient mice","volume":"186","author":"Mizgerd","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drup.2016.10.001_bib0725","doi-asserted-by":"crossref","first-page":"e0127032","DOI":"10.1371\/journal.pone.0127032","article-title":"The role of heparanase in pulmonary cell recruitment in response to an allergic but not non-allergic stimulus","volume":"10","author":"Morris","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2016.10.001_bib0730","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0140-6736(93)90485-Y","article-title":"Disruption of sulphated glycosaminoglycans in intestinal inflammation","volume":"341","author":"Murch","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2016.10.001_bib0735","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1242\/jcs.115.10.2179","article-title":"Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts","volume":"115","author":"Nadav","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.drup.2016.10.001_bib0740","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/j.1538-7836.2006.02212.x","article-title":"Heparanase induces tissue factor expression in vascular endothelial and cancer cells","volume":"4","author":"Nadir","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.drup.2016.10.001_bib0745","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3324\/haematol.2010.023713","article-title":"Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII","volume":"95","author":"Nadir","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.drup.2016.10.001_bib0750","doi-asserted-by":"crossref","first-page":"12103","DOI":"10.1074\/jbc.M414217200","article-title":"Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting","volume":"280","author":"Naggi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0755","first-page":"3","article-title":"The role of heparanase in gastrointestinal cancer","volume":"14","author":"Naomoto","year":"2005","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.drup.2016.10.001_bib0760","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/310241a0","article-title":"Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase","volume":"310","author":"Naparstek","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.drup.2016.10.001_bib0765","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1242\/jcs.146365","article-title":"TFEB at a glance","volume":"129","author":"Napolitano","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.drup.2016.10.001_bib0770","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/bi030203a","article-title":"Mechanism of activation of human heparanase investigated by protein engineering","volume":"43","author":"Nardella","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.drup.2016.10.001_bib0775","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbrc.2005.03.129","article-title":"Emergence of nuclear heparanase induces differentiation of human mammary cancer cells","volume":"331","author":"Nobuhisa","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drup.2016.10.001_bib0780","doi-asserted-by":"crossref","first-page":"e85944","DOI":"10.1371\/journal.pone.0085944","article-title":"Heparanase interacts with resistin and augments its activity","volume":"9","author":"Novick","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2016.10.001_bib0785","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1078-0432.1028.11.3","article-title":"Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer","volume":"11","author":"Ogishima","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0790","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/S0021-9258(19)41657-8","article-title":"Cleavage of macromolecular heparin by an enzyme from mouse mastocytoma","volume":"250","author":"Ogren","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0795","doi-asserted-by":"crossref","first-page":"42488","DOI":"10.1074\/jbc.M206510200","article-title":"Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence","volume":"277","author":"Okada","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0800","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1158\/1535-7163.MCT-12-1123","article-title":"PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic cancer","volume":"12","author":"Ostapoff","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2016.10.001_bib0805","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2012.09.030","article-title":"Increased expression of heparanase in symptomatic carotid atherosclerosis","volume":"226","author":"Osterholm","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.drup.2016.10.001_bib0810","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1189\/jlb.0313147","article-title":"Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP","volume":"95","author":"Ostrovsky","year":"2014","journal-title":"J. Leukoc. Biol."},{"issue":"Suppl. 19\u201330","key":"10.1016\/j.drup.2016.10.001_bib0815","first-page":"11","article-title":"Rab27a and Rab27b control different steps of the exosome secretion pathway","volume":"12","author":"Ostrowski","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0820","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/glycob\/cww003","article-title":"Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase","volume":"26","author":"Pala","year":"2016","journal-title":"Glycobiology"},{"key":"10.1016\/j.drup.2016.10.001_bib0825","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3324\/haematol.2009.017913","article-title":"Melphalan, prednisone, thalidomide and defibrotide in relapsed\/refractory multiple myeloma: results of a multicenter phase I\/II trial","volume":"95","author":"Palumbo","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.drup.2016.10.001_bib0830","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1440-1711.1998.00722.x","article-title":"Treatment of central nervous system inflammation with inhibitors of basement membrane degradation","volume":"76","author":"Parish","year":"1998","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0835","first-page":"M99","article-title":"Heparanase: a key enzyme involved in cell invasion","volume":"1471","author":"Parish","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drup.2016.10.001_bib0840","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nri1918","article-title":"The role of heparan sulphate in inflammation","volume":"6","author":"Parish","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.drup.2016.10.001_bib0845","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.matbio.2013.02.007","article-title":"Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation","volume":"32","author":"Parish","year":"2013","journal-title":"Matrix Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0850","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcancer.2011.01.002","article-title":"The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts","volume":"21","author":"Peinado","year":"2011","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0855","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"18","author":"Peinado","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2016.10.001_bib0860","doi-asserted-by":"crossref","first-page":"14504","DOI":"10.1074\/jbc.M110.104166","article-title":"Unraveling the specificity of heparanase utilizing synthetic substrates","volume":"285","author":"Peterson","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0865","doi-asserted-by":"crossref","first-page":"34836","DOI":"10.1074\/jbc.M112.390161","article-title":"Deciphering mode of action of heparanase using structurally defined oligosaccharides","volume":"287","author":"Peterson","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0870","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1096\/fj.201500046","article-title":"Lung ICAM-1 and ICAM-2 support spontaneous intravascular effector lymphocyte entrapment but are not required for neutrophil entrapment or emigration inside endotoxin-inflamed lungs","volume":"30","author":"Petrovich","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.drup.2016.10.001_bib0875","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000341498","article-title":"Barrett\u2019s to oesophageal cancer sequence: a model of inflammatory-driven upper gastrointestinal cancer","volume":"29","author":"Picardo","year":"2012","journal-title":"Dig. Surg."},{"key":"10.1016\/j.drup.2016.10.001_bib0880","doi-asserted-by":"crossref","first-page":"18770","DOI":"10.1074\/jbc.273.30.18770","article-title":"Substrate specificity of heparanases from human hepatoma and platelets","volume":"273","author":"Pikas","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0885","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcp.2014.02.010","article-title":"The potential of heparanase as a therapeutic target in cancer","volume":"89","author":"Pisano","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drup.2016.10.001_bib0890","doi-asserted-by":"crossref","first-page":"e18370","DOI":"10.1371\/journal.pone.0018370","article-title":"Role of heparanase on hepatic uptake of intestinal derived lipoprotein and fatty streak formation in mice","volume":"6","author":"Planer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2016.10.001_bib0895","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/eji.201343645","article-title":"Mice deficient in heparanase exhibit impaired dendritic cell migration and reduced airway inflammation","volume":"44","author":"Poon","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.drup.2016.10.001_bib0900","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/138161210789941793","article-title":"Mechanisms of tumor cell necrosis","volume":"16","author":"Proskuryakov","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drup.2016.10.001_bib0905","doi-asserted-by":"crossref","first-page":"32628","DOI":"10.1074\/jbc.M806266200","article-title":"Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma","volume":"283","author":"Purushothaman","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0910","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1182\/blood-2009-07-234757","article-title":"Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis","volume":"115","author":"Purushothaman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.drup.2016.10.001_bib0915","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1074\/jbc.M115.686295","article-title":"Fibronectin on the surface of myeloma cell-derived exosomes mediates exosome\u2013cell interactions","volume":"291","author":"Purushothaman","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0920","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.drup.2016.10.001_bib0925","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1074\/jbc.M110.183277","article-title":"Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity","volume":"286","author":"Ramani","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0930","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.1074\/jbc.M111.330803","article-title":"Heparan sulfate chains of syndecan-1 regulate ectodomain shedding","volume":"287","author":"Ramani","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0935","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1111\/febs.12168","article-title":"The heparanase\/syndecan-1 axis in cancer: mechanisms and therapies","volume":"280","author":"Ramani","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.drup.2016.10.001_bib0940","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.18632\/oncotarget.6408","article-title":"Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma","volume":"7","author":"Ramani","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2016.10.001_bib0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.matbio.2016.03.006","article-title":"Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype","author":"Ramani","year":"2016","journal-title":"Matrix Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0950","doi-asserted-by":"crossref","first-page":"12366","DOI":"10.1074\/jbc.M112.435172","article-title":"Characterization of heparanase-induced phosphatidylinositol 3-kinase-AKT activation and its integrin dependence","volume":"288","author":"Riaz","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0955","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1158\/1078-0432.CCR-10-2476","article-title":"SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase\/syndecan-1 axis","volume":"17","author":"Ritchie","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0960","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4155\/fmc-2016-0012","article-title":"Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases","volume":"8","author":"Rivara","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib0965","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/carcin\/bgr031","article-title":"The multiple roles of autophagy in cancer","volume":"32","author":"Rosenfeldt","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.drup.2016.10.001_bib0970","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/cr.2015.29","article-title":"Heparanase activates the syndecan\u2013syntenin\u2013ALIX exosome pathway","volume":"25","author":"Roucourt","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0975","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/cr.2015.29","article-title":"Heparanase activates the syndecan\u2013syntenin\u2013ALIX exosome pathway","volume":"25","author":"Roucourt","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.drup.2016.10.001_bib0980","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.matbio.2012.05.001","article-title":"Targeting heparanase for cancer therapy at the tumor\u2013matrix interface","volume":"31","author":"Sanderson","year":"2012","journal-title":"Matrix Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib0985","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10585-007-9125-3","article-title":"Syndecan-1: a dynamic regulator of the myeloma microenvironment","volume":"25","author":"Sanderson","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.drup.2016.10.001_bib0990","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.4049\/jimmunol.172.6.3830","article-title":"Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate","volume":"172","author":"Sasaki","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.drup.2016.10.001_bib0995","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2843","article-title":"The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis","volume":"18","author":"Schmidt","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2016.10.001_bib1000","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00204-012-0998-9","article-title":"Non-melanoma skin cancer in mouse and man","volume":"87","author":"Schwarz","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.drup.2016.10.001_bib1005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2016.10.001_bib1010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1515\/bmc-2015-0021","article-title":"Recent data concerning heparanase: focus on fibrosis, inflammation and cancer","volume":"6","author":"Secchi","year":"2015","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.drup.2016.10.001_bib1015","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/emboj.2012.32","article-title":"A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB","volume":"31","author":"Settembre","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.drup.2016.10.001_bib1020","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1582-4934.2010.01190.x","article-title":"Pre-clinical and clinical significance of heparanase in Ewing\u2019s sarcoma","volume":"15","author":"Shafat","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.drup.2016.10.001_bib1025","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1038\/onc.2014.403","article-title":"The tumor microenvironment shapes hallmarks of mature B-cell malignancies","volume":"34","author":"Shain","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2016.10.001_bib1030","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1007\/s00018-014-1629-9","article-title":"Processing of heparanase is mediated by syndecan-1 cytoplasmic domain and involves syntenin and alpha-actinin","volume":"71","author":"Shteingauz","year":"2014","journal-title":"J. Cell. Mol. Life Sci. (CMLS)"},{"key":"10.1016\/j.drup.2016.10.001_bib1035","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1158\/0008-5472.CAN-15-0037","article-title":"Heparanase enhances tumor growth and chemoresistance by promoting autophagy","volume":"75","author":"Shteingauz","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib1040","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1038\/sj.onc.1207056","article-title":"Role of promoter methylation in regulation of the mammalian heparanase gene","volume":"22","author":"Shteper","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2016.10.001_bib1045","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1349-7006.2004.tb02485.x","article-title":"Heparanase as a molecular target of cancer chemotherapy","volume":"95","author":"Simizu","year":"2004","journal-title":"Cancer Sci."},{"key":"10.1016\/j.drup.2016.10.001_bib1050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ceb.2009.03.007","article-title":"Exosomes\u2014vesicular carriers for intercellular communication","volume":"21","author":"Simons","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib1055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2559.2010.03594.x","article-title":"Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett\u2019s oesophagus and intestinal-type gastric carcinoma","volume":"57","author":"Sonoda","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.drup.2016.10.001_bib1060","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1096\/fj.14-265447","article-title":"Heparanase of murine effector lymphocytes and neutrophils is not required for their diapedesis into sites of inflammation","volume":"29","author":"Stoler-Barak","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.drup.2016.10.001_bib1065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2014.02.001","article-title":"Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme","volume":"728","author":"Tayel","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drup.2016.10.001_bib1070","doi-asserted-by":"crossref","first-page":"10093","DOI":"10.1074\/jbc.C112.444562","article-title":"Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes","volume":"288","author":"Thompson","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib1075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/bies.950180208","article-title":"Supramolecular assembly of basement membranes","volume":"18","author":"Timpl","year":"1996","journal-title":"Bioessays"},{"key":"10.1016\/j.drup.2016.10.001_bib1080","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","article-title":"Communication by extracellular vesicles: where we are and where we need to go","volume":"164","author":"Tkach","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.drup.2016.10.001_bib1085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.RES.0000159708.71142.c8","article-title":"Syndecans: new kids on the signaling block","volume":"96","author":"Tkachenko","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.drup.2016.10.001_bib1090","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/sj.ki.5001985","article-title":"Increased expression of heparanase in overt diabetic nephropathy","volume":"70","author":"van den Hoven","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.drup.2016.10.001_bib1095","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.ki.5002337","article-title":"Heparanase in glomerular diseases","volume":"72","author":"van den Hoven","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.drup.2016.10.001_bib1100","first-page":"999","article-title":"Multiple myeloma: 2014 update on diagnosis, risk-stratification, and management","volume":"89","author":"Vincent Rajkumar","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.drup.2016.10.001_bib1105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI13662","article-title":"Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis","volume":"108","author":"Vlodavsky","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drup.2016.10.001_bib1110","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0968-0004(91)90102-2","article-title":"Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism?","volume":"16","author":"Vlodavsky","year":"1991","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.drup.2016.10.001_bib1115","first-page":"112","article-title":"Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation","volume":"12","author":"Vlodavsky","year":"1992","journal-title":"Invasion Metastasis"},{"key":"10.1016\/j.drup.2016.10.001_bib1120","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/10518","article-title":"Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis","volume":"5","author":"Vlodavsky","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2016.10.001_bib1125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12307-011-0082-7","article-title":"Significance of heparanase in cancer and inflammation","volume":"5","author":"Vlodavsky","year":"2012","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.drup.2016.10.001_bib1130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.matbio.2013.03.002","article-title":"Involvement of heparanase in atherosclerosis and other vessel wall pathologies","volume":"32","author":"Vlodavsky","year":"2013","journal-title":"Matrix Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib1135","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1582-4934.2007.00039.x","article-title":"Mammalian heparanase: what is the message?","volume":"11","author":"Vreys","year":"2007","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.drup.2016.10.001_bib1140","doi-asserted-by":"crossref","first-page":"33141","DOI":"10.1074\/jbc.M503007200","article-title":"Cellular uptake of mammalian heparanase precursor involves low density lipoprotein receptor-related proteins mannose 6-phosphate receptors, and heparan sulfate proteoglycans","volume":"280","author":"Vreys","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2016.10.001_bib1145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/modpathol.3800282","article-title":"Positive association of heparanase expression with tumor invasion and lymphatic metastasis in gastric carcinoma","volume":"18","author":"Wang","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.drup.2016.10.001_bib1150","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1158\/1940-6207.CAPR-11-0083","article-title":"Multiple antigenic peptides of human heparanase elicit a much more potent immune response against tumors","volume":"4","author":"Wang","year":"2011","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.drup.2016.10.001_bib1155","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcjd.2013.05.008","article-title":"The function of heparanase in diabetes and its complications","volume":"37","author":"Wang","year":"2013","journal-title":"Can. J. Diab."},{"key":"10.1016\/j.drup.2016.10.001_bib1160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/modpathol.3800710","article-title":"Heparanase upregulation by colonic epithelium in inflammatory bowel disease","volume":"20","author":"Waterman","year":"2007","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.drup.2016.10.001_bib1165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev.bioeng.9.060906.151959","article-title":"The structure and function of the endothelial glycocalyx layer","volume":"9","author":"Weinbaum","year":"2007","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.drup.2016.10.001_bib1170","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1073\/pnas.1519453113","article-title":"Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis","volume":"113","author":"Weissmann","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drup.2016.10.001_bib1175","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc3262","article-title":"Deconvoluting the context-dependent role for autophagy in cancer","volume":"12","author":"White","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2016.10.001_bib1180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbrc.2013.11.079","article-title":"1H NMR spectroscopic studies establish that heparanase is a retaining glycosidase","volume":"443","author":"Wilson","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drup.2016.10.001_bib1185","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ejca.2015.02.007","article-title":"PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples","volume":"51","author":"Winterhoff","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.drup.2016.10.001_bib1190","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1074\/mcp.M115.052944","article-title":"Exosomes secreted by apoptosis-resistant acute myeloid leukemia (AML) blasts harbor regulatory network proteins potentially involved in antagonism of apoptosis","volume":"15","author":"Wojtuszkiewicz","year":"2016","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.drup.2016.10.001_bib1195","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1126\/science.2749255","article-title":"Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries","volume":"245","author":"Worthen","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.drup.2016.10.001_bib1200","first-page":"255","article-title":"Hypoxia activates heparanase expression in an NF-kappaB dependent manner","volume":"23","author":"Wu","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.drup.2016.10.001_bib1205","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/onc.2011.295","article-title":"The autophagic paradox in cancer therapy","volume":"31","author":"Wu","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2016.10.001_bib1210","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nsmb.3136","article-title":"Structural characterization of human heparanase reveals insights into substrate recognition","volume":"22","author":"Wu","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib1215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.drup.2016.10.001_bib1220","first-page":"1601","article-title":"Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells in vitro and in vivo","volume":"40","author":"Xiong","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.drup.2016.10.001_bib1225","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1158\/0008-5472.CAN-10-2179","article-title":"Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib1230","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.thromres.2006.10.026","article-title":"The anti-inflammatory effects of heparin and related compounds","volume":"122","author":"Young","year":"2008","journal-title":"Thromb. Res."},{"key":"10.1016\/j.drup.2016.10.001_bib1235","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1111\/j.1582-4934.2010.01127.x","article-title":"Endogenous toll-like receptor ligands and their biological significance","volume":"14","author":"Yu","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.drup.2016.10.001_bib1240","first-page":"144","article-title":"Dual character of Toll-like receptor signaling: pro-tumorigenic effects and anti-tumor functions","volume":"1835","author":"Yu","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drup.2016.10.001_bib1245","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0002-9440(10)62321-8","article-title":"Heparanase regulates murine hair growth","volume":"166","author":"Zcharia","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.drup.2016.10.001_bib1250","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1096\/fj.04-1970com","article-title":"Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models","volume":"19","author":"Zcharia","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.drup.2016.10.001_bib1255","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1242\/jcs.01068","article-title":"Processing and activation of latent heparanase occurs in lysosomes","volume":"117","author":"Zetser","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.drup.2016.10.001_bib1260","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1158\/0008-5472.CAN-05-1811","article-title":"Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation","volume":"66","author":"Zetser","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib1265","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1158\/1078-0432.CCR-10-1489","article-title":"Exosomes and cancer: a newly described pathway of immune suppression","volume":"17","author":"Zhang","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2016.10.001_bib1270","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.exer.2010.05.004","article-title":"Focus on molecules: heparanase","volume":"91","author":"Zhang","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.drup.2016.10.001_bib1275","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.drudis.2011.02.015","article-title":"Heparanase: a universal immunotherapeutic target in human cancers","volume":"16","author":"Zhang","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drup.2016.10.001_bib1280","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3892\/ol.2012.703","article-title":"Overexpression of heparanase multiple antigenic peptide 2 is associated with poor prognosis in gastric cancer: potential for therapy","volume":"4","author":"Zhang","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.drup.2016.10.001_bib1285","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-012-0997-1","article-title":"Heparanase overexpression impairs inflammatory response and macrophage-mediated clearance of amyloid-beta in murine brain","volume":"124","author":"Zhang","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.drup.2016.10.001_bib1290","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.matbio.2013.12.009","article-title":"Implications of heparan sulfate and heparanase in neuroinflammation","volume":"35","author":"Zhang","year":"2014","journal-title":"Matrix Biol."},{"key":"10.1016\/j.drup.2016.10.001_bib1295","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neo.2014.11.007","article-title":"Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer","volume":"17","author":"Zhang","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.drup.2016.10.001_bib1300","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/leu.2012.272","article-title":"PSGL-1\/selectin and ICAM-1\/CD18 interactions are involved in macrophage-induced drug resistance in myeloma","volume":"27","author":"Zheng","year":"2013","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.drup.2016.10.001_bib1305","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.18632\/oncotarget.2732","article-title":"Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance","volume":"20","author":"Zhitomirsky","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2016.10.001_bib1310","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drup.2015.11.004","article-title":"Lysosomes as mediators of drug resistance in cancer","volume":"24","author":"Zhitomirsky","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2016.10.001_bib1315","doi-asserted-by":"crossref","first-page":"e21106","DOI":"10.1371\/journal.pone.0021106","article-title":"M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2016.10.001_bib1320","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ccr.2012.12.001","article-title":"NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers","volume":"23","author":"Zhou","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2016.10.001_bib1325","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1172\/JCI46177","article-title":"Heparan sulfate and heparanase play key roles in mouse beta cell survival and autoimmune diabetes","volume":"122","author":"Ziolkowski","year":"2012","journal-title":"J. Clin. Investig."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764616300462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764616300462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T21:25:53Z","timestamp":1657401953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764616300462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":265,"alternative-id":["S1368764616300462"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2016.10.001","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparanase: From basic research to therapeutic applications in cancer and inflammation","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2016.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}